💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Lifevantage Corporation (LXRX)
« Back to company indexLXRX Chatter Timeline
Stock Ticker for LXRX
Most Active Tweeters for LXRX
| User | Tweets |
|---|---|
| @WeekHerald | 4 |
| @EnterpriseLeade | 2 |
| @stocknewstimes | 2 |
| @fintel_io | 1 |
| @AmericanBanking | 1 |
Recent Tweets for LXRX
 |
@EdgarInsider A Form 8-K [Press/News Current Report] filing has been made with the SEC: $LXRX #LexiconPharmaceuticals, Inc https://t.co/kNYnZD95fP October 22nd 2020, 7:10am |
 |
@fintel_io $LXRX / Lexicon Pharmaceuticals files form 8-K - Entry into a Material Definitive Agreement, Financial Statements a… https://t.co/8DN676uskV October 22nd 2020, 7:10am |
 |
@FlashAlert_me $LXRX [15s. delayed] filed form 8-K on October 22, 07:12:54: Item1.01: Entry into a Material Definitive Agreement https://t.co/lY5PTWRGKr October 22nd 2020, 7:10am |
 |
@OlympiaReport Lexicon Pharmaceuticals, Inc. $LXRX Short Interest Down 14.4% in September https://t.co/1f37mCAURw October 20th 2020, 6:10pm |
 |
@WeekHerald Lexicon Pharmaceuticals, Inc. $LXRX Short Interest Down 14.4% in September https://t.co/eBlcqbzniy October 20th 2020, 6:10pm |
|
@WeekHerald Zacks: Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Earnings of $0.45 Per Share https://t.co/Xy3x8TXBXE October 18th 2020, 4:10pm |
|
@WeekHerald Lexicon Pharmaceuticals $LXRX Coverage Initiated by Analysts at JPMorgan Chase & Co. https://t.co/Gk2XuSXkli October 18th 2020, 7:10am |
|
@WeekHerald Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $119.16 Million https://t.co/YJC5Ba8HrL October 16th 2020, 3:10pm |
 |
@RonDeckard RT @stocknewstimes: Lexicon Pharmaceuticals $LXRX Earns Underweight Rating from Analysts at JPMorgan Chase & Co. https://t.co/G99vyw0Hhw October 15th 2020, 12:10pm |
 |
@StockPyf Take a look at this Watchlist: $LXRX #scnDollHiVol DateTime: 2020-10-14 14:35 ET October 14th 2020, 2:10pm |
 |
@AmericanBanking Lexicon Pharmaceuticals $LXRX Research Coverage Started at JPMorgan Chase & Co. https://t.co/IyyJuYj4fk #stocks October 14th 2020, 10:10am |
 |
@EnterpriseLeade Lexicon Pharmaceuticals $LXRX Earns Underweight Rating from Analysts at JPMorgan Chase & Co. https://t.co/yllWOQw52k October 14th 2020, 9:10am |
 |
@TranscriptDaily Lexicon Pharmaceuticals $LXRX Earns Underweight Rating from Analysts at JPMorgan Chase & Co. https://t.co/PG1DtsBMF6 October 14th 2020, 9:10am |
 |
@stocknewstimes Lexicon Pharmaceuticals $LXRX Earns Underweight Rating from Analysts at JPMorgan Chase & Co. https://t.co/G99vyw0Hhw October 14th 2020, 9:10am |
 |
@sbwcws Lexicon resumed with an Underweight at JPMorgan $LXRX October 14th 2020, 8:10am |
|
@stocknewstimes $0.21 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/HgzteSjvFt October 14th 2020, 8:10am |
 |
@sublimetrades3 RT @SublimeTrades: Nice over-extended gap down trade today on $LXRX. Caught this with a new scan I just built with @StocksToTrade Missed th… October 12th 2020, 8:10am |
 |
@ThisLincolnian Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of $0.21 Per Share https://t.co/dHKunhveG1 October 11th 2020, 4:10am |
|
@EnterpriseLeade Lexicon Pharmaceuticals $LXRX Shares Up 5.4% https://t.co/w2YErtVKwG October 10th 2020, 9:10am |
|
@AmericanBanking Lexicon Pharmaceuticals $LXRX Stock Price Up 5.4% https://t.co/aTgMH60pwF #stocks October 8th 2020, 8:10pm |
 |
@MarcJacksonLA $LXRX Lexicon Pharmaceuticals Enters Agreement For Exchange Of Senior Notes To Reduce Its Outstanding Debt… https://t.co/oo43EGszUc October 6th 2020, 4:10pm |
|
@StockPyf Take a look at this Watchlist: $LXRX $RIGL #scnDollHiVol DateTime: 2020-10-06 11:47 ET October 6th 2020, 11:10am |
 |
@ChartMill $LXRX is valued rather cheaply when comparing the Enterprise Value to EBITDA ratio to the industry average of 1 ...… https://t.co/bO2SqxGRhW October 4th 2020, 9:10pm |
 |
@TekATL3 $LXRX see if this is the dip needed to stoke some watches September 30th 2020, 2:09pm |
|
@fintel_io $LXRX / Lexicon Pharmaceuticals files form 8-K - Unregistered Sales of Equity Securities - 8-K https://t.co/ofGYNjSQ5N September 29th 2020, 7:09am |
|
@EdgarInsider SEC Form 8-K [Press/News Current Report] filed by $LXRX #LexiconPharmaceuticals, Inc https://t.co/VV8ZXwJAuW September 29th 2020, 7:09am |
|
@FlashAlert_me $LXRX [15s. delayed] filed form 8-K on September 29, 07:14:04: Item3.02: Unregistered Sales of Equity Securities https://t.co/dbn9BXiH0Q September 29th 2020, 7:09am |
 |
@S_AnglinIV @petedoom Happen to me this morning with $STAF and happened a while back with $LXRX both had great PR’s and numbers… https://t.co/IhILCtkKkf September 28th 2020, 10:09am |
 |
@whothislib @_ms_izzy would you consider this a good example of a Tweezer bottom? $LXRX entirely reversing the previous days lo… https://t.co/u1As1j1m5K September 28th 2020, 6:09am |
 |
@thestockkira $LXRX if it holds this range I'll buy in, otherwise looking for mid 1.3s September 24th 2020, 3:09pm |
|
@thestockkira $LXRX when it settles, ill grab for a swing to 2 September 24th 2020, 11:09am |
|
@MarcJacksonLA $LXRX Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness https://t.co/T901OVE3EY September 24th 2020, 11:09am |
 |
@bioILLOGICAL $LXRX Invus uber bag holder with 56% of the company with avg $10.93/shr. Other than that, a bunch of mutual funds.… https://t.co/JpFFwogvNk September 24th 2020, 9:09am |
|
@bioILLOGICAL $LXRX nicely cleaning up debt on balance sheet and recently closing on XERMELO divestment. Now just needs to moneti… https://t.co/nVHei4T9bE September 24th 2020, 9:09am |
|
@EdgarInsider A Form 8-K [Press/News Current Report] filing has been made with the SEC: $LXRX #LexiconPharmaceuticals, Inc https://t.co/7cskUasTbE September 24th 2020, 7:09am |
|
@FlashAlert_me $LXRX [15s. delayed] filed form 8-K on September 24, 07:12:23: Item3.02: Unregistered Sales of Equity Securities https://t.co/C5sr70ILY2 September 24th 2020, 7:09am |
|
@RonDeckard RT @HealthcareBeat: Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness $LXRX https:/… September 24th 2020, 7:09am |
|
@RonDeckard RT @Kevin_W81: $LXRX $1.5's Friendly reminder, they are loaded with cash after this deal end of July ?? https://t.co/zPyTJPlkvE September 24th 2020, 6:09am |
|
@RonDeckard RT @Briefingcom: $LXRX: Lexicon Pharma agreements to exchange convertible notes; has reduced its outstanding debt by ~90% in Q3 https://t.c… September 24th 2020, 6:09am |
|
@RonDeckard RT @MarketCurrents: $LXRX - Lexicon Pharmaceuticals launches exchange offer for convertible 2021 notes https://t.co/ajRCZ5xArx September 24th 2020, 6:09am |
 |
@Briefingcom $LXRX: Lexicon Pharma agreements to exchange convertible notes; has reduced its outstanding debt by ~90% in Q3 https://t.co/amhO63JWOt September 24th 2020, 6:09am |
 |
@MarketCurrents $LXRX - Lexicon Pharmaceuticals launches exchange offer for convertible 2021 notes https://t.co/ajRCZ5xArx September 24th 2020, 6:09am |
 |
@quant_data Lexicon Pharmaceuticals Announced Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness Related Tickers: $LXRX September 24th 2020, 5:09am |
 |
@biscuitparty RT @S_AnglinIV: $LXRX announced agreements to exchange convertible notes. Helps get rid of debt !! Nice will keep watch September 24th 2020, 5:09am |
|
@S_AnglinIV $LXRX announced agreements to exchange convertible notes. Helps get rid of debt !! Nice will keep watch September 24th 2020, 5:09am |
 |
@1stOncology #LexiconPharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness $LXRX https://t.co/h8416SGOTC September 24th 2020, 5:09am |
 |
@preticks Latest headline: (NASDAQ: $LXRX) Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce O… https://t.co/3v5HFINEtV September 23rd 2020, 7:09pm |
 |
@nick82gh RT @BottomPickerDTs: Taking some $LXRX overnight on this news September 23rd 2020, 7:09pm |
 |
@BottomPickerDTs Taking some $LXRX overnight on this news September 23rd 2020, 6:09pm |
 |
@holiday613 $LXRX took .15 on 1/2 position. .holding balance for tomorrow... https://t.co/TL48pO2ycB September 23rd 2020, 6:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
